Immunosuppression and HIV Infection: A Therapeutic Challenge
The optimal use of biological response modifiers (BRMs) in human immunodeficiency virus (HIV)-related disease depends on knowledge of the molecular basis of the immune deficiencies and dysregulations that occur during the course of the infection; evidence for the role of viral products and cytokines...
Saved in:
| Main Authors: | Sandra H Bridges, Margaret I Johnston, John J McGowan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1992-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1992/740587 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis
by: Li W, et al.
Published: (2025-01-01) -
Factors affecting the rate of immunosuppression development in children with HIV infection
by: V. B. Denisenko, et al.
Published: (2022-04-01) -
Severe Primary HSV-2 in a Perinatal HIV-Infected Woman with Advanced Immunosuppression
by: Lana Lee, et al.
Published: (2012-01-01) -
Acalculous Cholecystitis caused by Histoplasma capsulatum in a severely immunosuppressed HIV-infected patient
by: Jorge Alave, et al.
Published: (2011-03-01) -
Bread, butter and marmite
by: Suzanne McGowan
Published: (2011-04-01)